10 Most Overvalued AI Stocks According to Short Sellers

Page 1 of 3

The U.S. stock market has suffered a broad sell-off heading into year-end, driven by renewed concerns about elevated AI valuations and uncertainty surrounding the profitability of artificial intelligence investments.

Short sellers are increasingly piling pressure amid concerns that technology companies have committed enormous amounts of capital to AI infrastructure without demonstrating that the resulting investments will generate sufficient returns. The selloff has also given rise to buy-the-dip moves as insiders start to load up.

The pressure has extended beyond major technology companies to smaller businesses that were expected to benefit from rising AI capital expenditure. The market rout wiped out about $3 trillion in S&P 500 market capitalization in early November, as the Nasdaq recorded its largest single-day decline in 19 months.

Michael Burry, the investor made famous by The Big Short, has raised concerns about the financial structure supporting the AI boom. Burry’s concern is that AI infrastructure companies could be relying on increasingly complicated financing arrangements that may become unsustainable. RSM Chief economist Joe Brusuelas is wary of a wholesale bursting of the AI bubble as uncertainty surrounding Nvidia undermines confidence among lenders and investors financing the massive data-center expansion.

Billionaire Stanley Druckenmiller has also become increasingly cautious about the stock market amid the AI sell-off. Take a look at his top 5 stock picks amid the concern.

Meanwhile, Barclays Chief Market Strategist Julien Lafargue has also warned that the AI sell-off is exposing a fundamental weakness in the investment cycle: the growing cost of financing AI infrastructure. According to Barclays, AI demand remains strong, but investors are questioning who will finance the enormous investments required to build data centers and computing infrastructure.

10 Most Overvalued AI Stocks According to Short Sellers

Anthropic’s highly anticipated IPO has provided another important test of investor confidence. Although the offering attracted substantial demand and raised $81 billion, its successful debut failed to reverse the broader weakness in AI-related stocks.

While Morgan Stanley argued that the November AI sell-off was excessive and presented a buying opportunity, there seems to be no reprieve. Goldman Sachs strategists, for their part, have warned that the outlook for AI investment and corporate profit margins in 2028 and beyond remains highly uncertain.

Our Methodology

For this article, we used stock screeners to scan for stocks with significant exposure to artificial intelligence technology. From the list, we focused on stocks considered overvalued and with open short interest above 10%. We explain why short sellers remain skeptical of these stocks and detail how many hedge funds hold stakes in them in Q3 2026. The stocks are ranked in ascending order of their short interest.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter strategy selects 14 small-cap and large-cap stocks every quarter and has returned 612% since May 2014, beating its benchmark by 375 percentage points (see more details here).

10. CoreWeave, Inc. (NASDAQ:CRWV)

Open Short Interest: 13.34%

Number of Hedge Fund Holders: 70

CoreWeave, Inc. (NASDAQ:CRWV) is facing substantial short-selling pressure because investors are concerned that its aggressive AI infrastructure expansion, high capital expenditure requirements, and uncertain path to sustainable free cash flow may not justify its valuation.

One of the biggest concerns is CoreWeave, Inc.’s reliance on debt to finance its AI infrastructure expansion. The company must invest heavily in GPUs, servers, networking equipment, and data centers before generating revenue from those assets, creating a significant financing challenge. You may want to look at why Jim Cramer doubled down on CRWV despite these concerns.

Management has already raised 2026 capital expenditure guidance to between $37 billion and $39 billion, compounded by expected fourth-quarter interest expense of between $1.05 billion and $1.15 billion. These financing requirements make CoreWeave particularly vulnerable to higher borrowing costs and tighter credit conditions.

Amid aggressive capital spending plans, revenue growth is not translating into positive net income, presenting another challenge. Revenue in the third quarter was up 168% to $3.66 billion, but the company ended with a net loss of $709 million and net interest expense of $846 million.

Therefore, short sellers are increasingly questioning whether CoreWeave, Inc. can generate sufficient returns from its infrastructure investments to cover financing costs and future expansion. Short sellers are also concerned that the company could struggle to raise additional financing on attractive terms if interest rates remain elevated or lenders become more cautious about AI infrastructure investments.

9. Tempus AI, Inc. (NASDAQ:TEM)

Open Short Interest: 13.45%

Number of Hedge Fund Holders: 43

Tempus AI, Inc. (NASDAQ:TEM) is facing heightened short-selling pressure as investors question whether its rapid growth in AI-powered healthcare solutions can translate into sustainable profitability and justify its premium valuation.

The company operates at the intersection of artificial intelligence, genomic sequencing, and healthcare data analytics. As of November 19, 2026, the stock trades at a price-to-sales multiple of 7.57x and a 7.1x forward enterprise-value-to-sales multiple. These are demanding multiples for a company that has yet to establish consistent GAAP profitability.

While Tempus AI, Inc. is growing rapidly, as depicted by revenue increasing 23% in the third quarter to $411.5 million, it is yet to attain sustainable GAAP profitability. While its quarterly net loss narrowed to $14.9 million from $80 million, the company continues to generate an operating loss.

Another concern is the gap between adjusted profitability and the company’s actual expenses. Tempus reported $50.8 million in stock-based compensation expense and related employer payroll taxes, nearly double $25.6 million adjusted EBITDA.

Meanwhile, Tempus AI, Inc. competes in an increasingly crowded healthcare AI market. The concern for short sellers is that having a large healthcare dataset does not automatically translate into recurring, high-margin revenue.

Therefore, the company needs to demonstrate that its proprietary data and AI platforms can generate predictable licensing revenue and become increasingly profitable as adoption expands. Is the data center business in danger?

Page 1 of 3